Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis-Reference-Cited by-同舟云学术

Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis

Published:2016-08-12 Issue:2 Volume:31 Page:294-303
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Augustin M.¹,Blome C.¹,Paul C.²,Puig L.³,Luger T.⁴,Lambert J.⁵,Chimenti S.⁶,Girolomoni G.⁷,Kragballe K.⁸,Naessens D.⁹,Bergmans P.¹⁰,Smirnov P.¹¹,Barker J.¹²,Reich K.¹³

Affiliation:

1. Institute for Health Services Research in Dermatology and Nursing (IVDP); German Center for Health Services Research in Dermatology (CVderm); University Medical Center Hamburg-Eppendorf (UKE); Hamburg Germany

2. Department of Dermatology; Paul Sabatier University; Toulouse France

3. Hospital de la Santa Creu i Sant Pau; Universitat Autònoma de Barcelona; Barcelona Spain

4. University of Münster; Münster Germany

5. Department of Dermatology; Ghent University Hospital; Ghent Belgium

6. University of Rome; Rome Italy

7. Department of Dermatology; University of Verona; Verona Italy

8. Århus University; Århus Denmark

9. Janssen Cilag NV; Beerse Belgium

10. Janssen-Cilag BV; Tilburg The Netherlands

11. Janssen Pharmaceutica NV; Moscow Russia

12. St John's Institute of Dermatology; King's College; London UK

13. Dermatologikum; Hamburg Germany

Funder

Janssen Pharmaceuticals

Sarah Maloney of GeoMed, an Ashfield company, part of UDG Healthcare plc

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.13823/fullpdf

Reference30 articles.

1. Quality-of-life issues in psoriasis;Mukhtar;Dermatol Clin,2004

2. Quality-of-life instruments: evaluation of the impact of psoriasis on patients;Heller;Dermatol Clin,2012

3. Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate-to-severe psoriasis using structural equation modeling;Lewis-Beck;Patient Prefer Adherence,2013

4. Adherence to medication in patients with psoriasis: a systematic literature review;Thorneloe;Br J Dermatol,2013

5. Impact of ustekinumab on health-related quality of life and sexual difficulties associated with psoriasis: results from two phase III clinical trials;Guenther;J Eur Acad Dermatol Venereol,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real world insights for psoriasis: the association of severity of skin lesions with work productivity, medical consumption costs and quality of life;Journal of Dermatological Treatment;2024-03-24

2. Goals and benefits in topical treatment for psoriasis: development and pilot validation of a patient-reported outcomes tool, the Patient Benefit Index for Topical Treatment (PBI-TOP);British Journal of Dermatology;2024-01-12

3. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-07-12

4. A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries;British Journal of Dermatology;2023-03-27

5. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2022-05-23